DOC-Stim (2020-2022) targeted communication and rehabilitation for patients with disorders of consciousness via BCI — a highly specialized clinical application where g.tec is the host technology provider.
G.TEC MEDICAL ENGINEERING SPAIN SL
Barcelona BCI technology SME applying brain-computer interfaces to rehabilitation for patients with disorders of consciousness.
Their core work
G.TEC Medical Engineering Spain SL is a Barcelona-based medical technology SME operating as the Spanish entity of the Austrian g.tec medical engineering group (gtec.at), a recognized specialist in Brain-Computer Interface (BCI) systems and neurotechnology. Their H2020 work covers two distinct health-technology areas: smart optical imaging and sensing for clinical applications, and BCI-driven communication and rehabilitation for patients with disorders of consciousness — a severe neurological condition that leaves patients unable to communicate despite being partially aware. In the DOC-Stim project, they served as the host institution for a Marie Skłodowska-Curie Individual Fellowship, meaning they provided the scientific environment and infrastructure for a researcher developing BCI-based therapy. Their core value lies at the intersection of medical device engineering, neuroscience, and digital health technologies.
What they specialise in
ASTONISH (2016-2019) was an ECSEL-RIA project advancing smart optical imaging and sensing for health, in which g.tec Spain participated as a contributor within a large industrial consortium.
DOC-Stim specifically targets patients with disorders of consciousness, placing the organization in the niche of assistive and rehabilitative neurotechnology for severe neurological conditions.
As coordinator of DOC-Stim under the MSCA-IF scheme, they demonstrated capacity to host and supervise advanced individual researchers — a capability that positions them as a research-active SME, not just a product company.
How they've shifted over time
Their H2020 trajectory runs from 2016 to 2022 across just two projects, but the shift is meaningful: they entered as a participant in a large ECSEL industrial consortium focused on optical imaging and sensing for health, then emerged as coordinator of a focused neurotechnology fellowship project on brain-computer interfaces. This suggests a strategic deepening — moving from broad digital health sensing toward their core competence in BCI and neurological rehabilitation. The transition from consortium participant to MSCA host institution also signals growing confidence in their scientific credibility and research infrastructure.
G.TEC Spain is consolidating around clinical BCI applications — particularly for non-communicative patients — which positions them as a specialist partner for future neurotechnology, assistive device, and digital therapeutics consortia.
How they like to work
G.TEC Spain has played both roles: a participant in a large ECSEL consortium (ASTONISH had an industrial-scale partnership with 26+ partners across 6 countries) and a coordinator hosting an MSCA Individual Fellowship. Their coordinator role is that of a research host rather than a project manager of a large consortium, which is typical of technology SMEs that bring proprietary platforms to research collaborations. This suggests they work best as a specialist technology provider with a concrete product or system — in their case, BCI hardware and software — that researchers or larger projects can plug into.
Their H2020 network spans 26 unique consortium partners across 6 countries, the bulk of which came through the large ECSEL-RIA project ASTONISH. Their geographic footprint is pan-European, consistent with both ECSEL and MSCA program requirements.
What sets them apart
G.TEC Spain is one of very few private SMEs in Southern Europe with demonstrated capacity to both join large ECSEL industrial consortia and independently host MSCA research fellows in the neurotechnology domain. Their connection to the wider g.tec group (Austria) gives them access to established BCI hardware platforms and clinical validation experience that most research groups or health-tech startups lack. For a consortium needing a credible, commercially-grounded BCI technology partner with clinical focus, they offer a rare combination of product maturity and research openness.
Highlights from their portfolio
- DOC-StimAs coordinator and MSCA host, g.tec Spain led a fellowship specifically targeting BCI-based communication for patients with disorders of consciousness — one of the most clinically challenging and ethically significant applications of neurotechnology.
- ASTONISHTheir largest funded project (EUR 267,000) and entry into H2020, participating in a pan-European ECSEL-RIA consortium advancing smart optical imaging for health applications — demonstrating early versatility beyond pure BCI work.